(Q38163815)

30 August 2017

title

Deregulation of microRNA expression in thyroid neoplasias (English)

1 reference

30 August 2017

0 references

4

1 reference

30 August 2017

Pierlorenzo Pallante

1

1 reference

30 August 2017

Sabrina Battista

series ordinal

2

1 reference

30 August 2017

Giovanna Maria Pierantoni

series ordinal

3

1 reference

30 August 2017

publication date

19 November 2013

1 reference

Nature Reviews Endocrinology

30 August 2017

published in

1 reference

30 August 2017

volume

10

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

88-101

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.223

30 August 2017

exact match

0 references

cites work

Regulation of mRNA translation and stability by microRNAs

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miRBase: tools for microRNA genomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNAs: target recognition and regulatory functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA gene expression deregulation in human breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The colorectal microRNAome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA signatures in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

A microRNA expression signature of human solid tumors defines cancer gene targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma"

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The demise of follicular carcinoma of the thyroid gland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Familial papillary thyroid microcarcinoma: a new clinical entity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The concise handbook of family cancer syndromes. Mayo Familial Cancer Program.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Dysfunction of the RET receptor in human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

BRAF mutation in thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Mutations of the BRAF gene in human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

A new mechanism of BRAF activation in human thyroid papillary carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Mutation of the PIK3CA gene in anaplastic thyroid cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The role of microRNA genes in papillary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA deregulation in human thyroid papillary carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

High basal levels of functional toll-like receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-221/222: promising biomarkers for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Retracted: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Galpha(q) and phospholipase C-beta: turn on, turn off, and do it fast.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Accurate molecular classification of renal tumors using microRNA expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Expression profiling identifies microRNA signature in pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Expression of microRNAs in patients with pancreatic cancer and its prognostic significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MYCN regulates oncogenic MicroRNAs in neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNAs expression signatures are associated with lineage and survival in acute leukemias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Gap junctions and connexin-interacting proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miRNA signature associated with outcome of gastric cancer patients following chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Functional analysis of microRNAs in human hepatocellular cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

TGF-β upregulates miR-181a expression to promote breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Genome regulation by polycomb and trithorax proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Role of the chromobox protein CBX7 in lymphomagenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Understanding the words of chromatin regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

A TSH-CREB1-microRNA loop is required for thyroid cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miRNA expression in colon polyps provides evidence for a multihit model of colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-1 targets Slug and endows lung cancer A549 cells with epithelial and anti-tumorigenic properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA profiling in human medulloblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA expression profiles associated with mutational status and survival in malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The microRNA-processing enzyme Dicer is essential for thyroid function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The let-7 microRNA represses cell proliferation pathways in human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

RAS is regulated by the let-7 microRNA family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Identification of let-7-regulated oncofetal genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Roles of HMGA proteins in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The polycomb group protein EZH2 is involved in progression of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

PDCD4 expression in thyroid neoplasia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Upregulation of miR-21 by Ras in vivo and its role in tumor growth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

miR-21: a small multi-faceted RNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Circulating microRNAs in cancer: origin, function and application

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Observer variation of encapsulated follicular lesions of the thyroid gland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Thyroid gland: international case conference.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Silencing of microRNAs in vivo with 'antagomirs'

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

LNA-mediated microRNA silencing in non-human primates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Thyroid carcinoma in atomic bomb survivors Hiroshima and Nagasaki,

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Cancer after nuclear fallout: lessons from the Chernobyl accident

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

Anaplastic thyroid carcinoma: a therapeutic challenge.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.223

MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival

31 March 2020

1 reference

12 December 2020

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer

1 reference

12 December 2020

Radiation exposure and thyroid cancer incidence among Hiroshima and Nagasaki residents

1 reference

12 December 2020

Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status.

1 reference

12 December 2020

Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer

1 reference

12 December 2020

The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.

1 reference

12 December 2020

miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells

1 reference

12 December 2020

MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2.

1 reference

12 December 2020

Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland

1 reference

12 December 2020

Presence of mutations in all three ras genes in human thyroid tumors

1 reference

12 December 2020

Transformation of thyroid epithelium is associated with loss of c-kit receptor

1 reference

12 December 2020

Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence

1 reference

12 December 2020

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

1 reference

12 December 2020

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

12 December 2020

Differential expression of specific microRNA and their targets in acute myeloid leukemia.

1 reference

12 December 2020

TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer

1 reference

12 December 2020

Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer

1 reference

12 December 2020

Analysis of miR-221 and p27 expression in human gliomas.

1 reference

12 December 2020

Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.223

1 reference

30 August 2017

1 reference